Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Lung Cancer
Inhibition of VEGFR and EGFR with Apatinib + Gefitinib as First-Line Therapy Increased Progression-Free Survival
Read More
Lung Cancer
Patritumab Deruxtecan Shows Promise in Treating Patients with EGFR-Mutated NSCLC
Read More
Lung Cancer
Bevacizumab + Osimertinib Did Not Increase Progression-Free Survival versus Osimertinib Alone in Patients with Advanced Adenocarcinoma and EGFR T790M Mutations
Read More
Lung Cancer
Lower Dose of Afatinib Shows Promising Clinical Efficacy in Patients with NSCLC and EGFR Mutation
Read More
Lung Cancer
ADAURA Trial: Osimertinib in Resected EGFR-Mutated NSCLC
Read More
Lung Cancer
Metastatic Non–Small-Cell Lung Cancer
David Spigel, MD
Read More
Lung Cancer
Nonmetastatic Non–Small-Cell Lung Cancer
Geoff Oxnard, MD
Read More
Lung Cancer
Small-Cell Lung Cancer and Mesothelioma
David Spigel, MD
Read More
Lung Cancer
Metastatic Non–Small-Cell Lung Cancer with Targetable Mutations
Geoff Oxnard, MD
Read More
FDA Oncology Update
,
Lung Cancer
Gavreto, a New RET Inhibitor, FDA Approved for Metastatic NSCLC with RET Fusions
Read More
4
5
6
7
8
9
10
Page 7 of 12
Results 61 - 70 of 114